NEW YORK, NY / ACCESSWIRE / March 19, 2015 / Stevia First Corp. (OTCBB:STVF) today published a new blog post on The Chairman's Blog, written by the Company's Chief Executive Officer, Robert Brooke. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

In his post, Mr. Brooke elaborates on the recently announced collaboration with a human gene company, in which SF Corp. intends to leverage their identification of genes that could be useful for treatment or prevention of diabetes and obesity in the pharmaceutical arena. Read the full blog post from Mr. Robert Brooke on TheChairmansBlog.com (http://www.thechairmansblog.com/stevia-first/robert-brooke/brave-new-medical-intervention-diabetes-obesity).

About Stevia First Corp.

Stevia First Corp. is an agricultural biotechnology company that is enabling dramatically healthier food and nutrition products. For more information visit: www.steviafirst.com and connect with the Company on Twitter, LinkedIn, Facebook and Google+.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com.

SOURCE: TheChairmansBlog.com